Next Article in Journal
Weight Loss Effects of Once-Weekly Semaglutide 2.4 mg in Adults with and Without Type 2 Diabetes: A Systematic Review and Meta-Analysis
Next Article in Special Issue
Click-to-Release for Controlled Immune Cell Activation: Tumor-Targeted Unmasking of an IL12 Prodrug
Previous Article in Journal
Taurine-Based Hybrid Drugs as Potential Anticancer Therapeutic Agents: In Vitro, In Vivo Evaluations
Previous Article in Special Issue
Enhanced Intranasal Delivery of Atorvastatin via Superparamagnetic Iron-Oxide-Loaded Nanocarriers: Cytotoxicity and Inflammation Evaluation and In Vivo, In Silico, and Network Pharmacology Study for Targeting Glioblastoma Management
 
 
Review

Article Versions Notes

Pharmaceuticals 2025, 18(7), 1057; https://doi.org/10.3390/ph18071057
Action Date Notes Link
article xml file uploaded 18 July 2025 12:06 CEST Original file -
article xml uploaded. 18 July 2025 12:06 CEST Update https://www.mdpi.com/1424-8247/18/7/1057/xml
article pdf uploaded. 18 July 2025 12:06 CEST Version of Record https://www.mdpi.com/1424-8247/18/7/1057/pdf
article html file updated 18 July 2025 12:10 CEST Original file https://www.mdpi.com/1424-8247/18/7/1057/html
Back to TopTop